
iHuman fell 66.2% from $2.96 to $1.00, behind the S&P 500's +11.0%. Its worst day was Nov 10 (−19.7%), and its low came Nov 13 at $0.99.
Nov 18, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.06 was reported on $28.9M revenue.
−0.9% · S&P 500 −0.4%
iHuman shares rose 9.9%, while the S&P 500 fell 1.4%.
Story events cover the past 12 months · Times ET
+9.9% · S&P 500 −1.4%
EPS of $0.04 was reported on $27.3M revenue.
+1.5% · S&P 500 +2.9%
iHuman shares rose 9.6%, while the S&P 500 fell 1.6%.
+9.6% · S&P 500 −1.6%
EPS of $0.01 was reported on $26.5M revenue.
+4.1% · S&P 500 +1.6%
iHuman shares rose 13.7%, while the S&P 500 rose 0.7%.
+13.7%, the year's best day, on 141K shares, the year's heaviest volume · S&P 500 +0.7%
EPS of $-0.05 was reported on $25.6M revenue.
−0.9% · S&P 500 −0.2%
iHuman shares fell 19.7%, while the S&P 500 fell 0.4%.
−19.7%, the year's worst day · S&P 500 −0.4%
Where it ended: a close of $1.00 on Nov 17, 2026. Up next: Q3 2026 earnings on Dec 28, 2026.
Nothing in the past 12 months.
All IH analyst actionsChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IH and SPY from Benzinga historical bars. Not investment advice.